Cementos Bio Bio Balance Sheet Health
Financial Health criteria checks 6/6
Cementos Bio Bio has a total shareholder equity of CLP274.5B and total debt of CLP101.4B, which brings its debt-to-equity ratio to 37%. Its total assets and total liabilities are CLP502.5B and CLP228.0B respectively. Cementos Bio Bio's EBIT is CLP42.6B making its interest coverage ratio 3.8. It has cash and short-term investments of CLP14.0B.
Key information
37.0%
Debt to equity ratio
CL$101.45b
Debt
Interest coverage ratio | 3.8x |
Cash | CL$14.03b |
Equity | CL$274.51b |
Total liabilities | CL$228.02b |
Total assets | CL$502.52b |
Recent financial health updates
Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?
May 10Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?
Jan 19Recent updates
Market Might Still Lack Some Conviction On Cementos Bio Bio S.A. (SNSE:CEMENTOS) Even After 86% Share Price Boost
Nov 20The Return Trends At Cementos Bio Bio (SNSE:CEMENTOS) Look Promising
Nov 20Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings
Apr 08Capital Allocation Trends At Cementos Bio Bio (SNSE:CEMENTOS) Aren't Ideal
Jun 06Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?
May 10Shareholders Of Cementos Bio Bio (SNSE:CEMENTOS) Must Be Happy With Their 79% Return
Mar 07Be Wary Of Cementos Bio Bio (SNSE:CEMENTOS) And Its Returns On Capital
Feb 14Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?
Jan 19Cementos Bio Bio (SNSE:CEMENTOS) Has Compensated Shareholders With A Respectable 74% Return On Their Investment
Dec 01Financial Position Analysis
Short Term Liabilities: CEMENTOS's short term assets (CLP143.7B) exceed its short term liabilities (CLP90.4B).
Long Term Liabilities: CEMENTOS's short term assets (CLP143.7B) exceed its long term liabilities (CLP137.6B).
Debt to Equity History and Analysis
Debt Level: CEMENTOS's net debt to equity ratio (31.8%) is considered satisfactory.
Reducing Debt: CEMENTOS's debt to equity ratio has reduced from 44.2% to 37% over the past 5 years.
Debt Coverage: CEMENTOS's debt is well covered by operating cash flow (49.9%).
Interest Coverage: CEMENTOS's interest payments on its debt are well covered by EBIT (3.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 19:11 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cementos Bio Bio S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Alex Sadzawka | BTG Pactual Chile S.A. Corredores de Bolsa |